<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The aim of the study was to compare the first-passage profiles of <z:chebi fb="0" ids="33377">dysprosium</z:chebi> <z:chebi fb="0" ids="30629">diethylenetriamine</z:chebi> penta-<z:chebi fb="22" ids="15366">acetic acid</z:chebi> bis(methylamide) (<z:chebi fb="0" ids="35739">DTPA</z:chebi> BMA) and the superparamagnetic <z:chebi fb="27" ids="50820">iron oxide</z:chebi> particles NSR 0430 in regions with severe and moderate <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>In seven rats subjected to middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp>, two dynamic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> perfusion imaging series were acquired after intravenous bolus injections of .5 mmol/kg <z:chebi fb="0" ids="33377">dysprosium</z:chebi> <z:chebi fb="0" ids="35739">DTPA</z:chebi> BMA and .06 mmolFe/kg <z:chebi fb="27" ids="50820">iron oxide</z:chebi> particles, respectively </plain></SENT>
<SENT sid="2" pm="."><plain>The doses were chosen to obtain similar maximum signal change in normally perfused brain </plain></SENT>
<SENT sid="3" pm="."><plain>The first-passage profiles were compared in a region of interest (ROI) in the core area with severe <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and in a ROI in the penumbra area of moderate <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>The results were compared both as the calculated mean signal intensity versus time curves for <z:hpo ids='HP_0000001'>all</z:hpo> seven rats and statistically for an estimated mean transit time (<z:chebi fb="0" ids="53233">MTT</z:chebi>) after gamma variate fitting of the calculated concentration versus time curves </plain></SENT>
<SENT sid="5" pm="."><plain>The first-passage profiles for the two contrast agents were similar, both in the core area of severe <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and in the penumbra area of moderate <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>In this rat <z:hpo ids='HP_0001297'>stroke</z:hpo> model, <z:chebi fb="0" ids="33377">dysprosium</z:chebi> <z:chebi fb="0" ids="35739">DTPA</z:chebi> BMA and the superparamagnetic <z:chebi fb="27" ids="50820">iron oxide</z:chebi> particles NSR 0430 were found to be equally efficacious for the diagnosis of the perfusion deficit, but if safe for human investigations, <z:chebi fb="27" ids="50820">iron oxide</z:chebi> particles would have an advantage as equal susceptibility effect may be achieved with smaller injection volumes </plain></SENT>
</text></document>